26.10.12

IBA Dosimetry Launches New Visicoil Twin Line

IBA (Ion Beam Applications S.A.), the global high tech leader in the next generation of radiation therapy and diagnostics for the treatment of cancer, announces the launch of the new VISICOIL Twin-Line fiducial marker at the annual meeting of the American Society for Radiation Oncology (ASTRO) - ASTRO booth #3019...